Kelly G. Davey, FNP

Kelly Davey practices at City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD in Irvine, California.

Kelly Davey's NPI, 1205192713, was assigned on April 9, 2012. Kelly Davey holds California license 95019912.

Kelly Davey's primary practice is City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD, at 1000 Fivepoint, Irvine, CA 92618.

Kelly Davey's primary practice is City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD in Irvine, California. The medical group on file is City of Hope. Dmand AI also links Kelly Davey to 1 more group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kelly Davey practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Kelly Davey's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Dmand AI has Kelly Davey's licenses on file in 2 states: California and New York.

Dmand AI lists acute gastroduodenitis, arthritis, fluid and electrolyte imbalances and shingles among the conditions Kelly Davey treats.

CMS data shows 507 Medicare services from Kelly Davey across 4 procedure codes in 2024, for 211 Medicare patients. Medicare paid $37,877 for them. Every service was in an office.

CMS counts 211 Medicare patients who saw Kelly Davey in 2024. The largest group is 75 to 84, with 96 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kelly Davey's median patient age at 72, with 49% women.

In 2024, Kelly Davey wrote 824 Medicare Part D claims for 155 patients. 59% of them were for generic drugs. CMS names the drug for 600 of them, across 25 drugs with 11 or more claims each, at $4,022,029 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Kelly Davey for performance year 2024, reported as part of a group. Kelly Davey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kelly Davey as offering telehealth.

CMS Open Payments shows 13 general payments to Kelly Davey from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $216.